Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -13.18M
June 30, 2026 -15.81M
March 31, 2026 -18.43M
December 31, 2025 -15.84M
September 30, 2025 -19.26M
June 30, 2025 -23.60M
March 31, 2025 -22.93M
December 31, 2024 -19.48M
September 30, 2024 -24.01M
June 30, 2024 -16.35M
March 31, 2024 -22.53M
December 31, 2023 -19.42M
Date Value
September 30, 2023 -16.48M
June 30, 2023 -17.68M
March 31, 2023 -15.42M
December 31, 2022 -13.39M
September 30, 2022 -20.97M
June 30, 2022 -12.64M
March 31, 2022 -12.27M
December 31, 2021 -5.986M
September 30, 2021
June 30, 2021
March 31, 2021 -2.83M
December 31, 2020 -0.088M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Korsana Biosciences, Inc. -46.83M
IRulya Therapeutics, Inc. -9.84M
Q32 Bio, Inc. -4.418M
Bridgebio Oncology Therapeutics, Inc. -28.36M
Oncolytics Biotech, Inc. -6.754M